ROC curve analyses were used to gauge the relative performance of TM9SF1 and a range of other clinical indicators (WBCs, lymphocytes, lymphocyte %, monocytes, monocyte %, neutrophils, neutrophil %, NLR, MLR, PLR, CRP, D-dimer, PaO2/FiO2 and SOFA) when predicting ARDS severity (Table 3). The gene discussed is CRP; the disease is acute respiratory distress syndrome.